Sign in
4

Changes in Ownership

GYRE THERAPEUTICS, INC. Filed Acc 0001209191-20-019038

Director bought 2,500 shares at $3.98 ($9,950)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Richard John P Director 2020-03-13 Purchase +2,500 $3.98 $9,950 3,716 D: show line 1 in the form
Open-market purchases · 2,500 sh · avg $3.98 · $9,950
Loading xslF345X03/doc4.xml…